Tricort-GC crema 0,5 mg + 10 mg + 1 mg/g Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

tricort-gc crema 0,5 mg + 10 mg + 1 mg/g

plethico pharmaceuticals ltd - betamethasonum + denumirea comuna internationala + gentamicinum - crema - 0,5 mg + 10 mg + 1 mg/g

Hetlioz Uniunea Europeană - română - EMA (European Medicines Agency)

hetlioz

vanda pharmaceuticals netherlands b.v. - tasimelteon - tulburări de somn, ritm circadian - psiholeptice - hetlioz este indicat pentru tratamentul de tulburări de somn-veghe non-24 de ore (non-24) la adulţi complet orb.

Hizentra Uniunea Europeană - română - EMA (European Medicines Agency)

hizentra

csl behring gmbh - imunoglobuline umane normale (scig) - sindroame de imunodeficiență - seruri imune și imunoglobuline, - replacement therapy in adults, children and adolescents (0-18 years) in:- primary immunodeficiency syndromes with impaired antibody production (see section 4. - secondary immunodeficiencies (sid) in patients who suffer from severe or recurrent infections, ineffective antimicrobial treatment and either proven specific antibody failure (psaf)* or serum igg level of.

Veraflox Uniunea Europeană - română - EMA (European Medicines Agency)

veraflox

bayer animal health gmbh  - pradofloxacinei - antibacteriene pentru uz sistemic, fluorochinolone - dogs; cats - dogstreatment de:rană infecții cauzate de tulpini sensibile din grupul staphylococcus intermedius (inclusiv s. pseudintermedius);piodermite superficiale și profunde cauzate de tulpini sensibile din grupul staphylococcus intermedius (inclusiv s. pseudintermedius);acută infecțiile urinare cauzate de tulpini sensibile de escherichia coli și staphylococcus intermedius grup (inclusiv s. pseudintermedius);ca tratament adjuvant mecanice sau chirurgicale parodontale terapie în tratamentul infecțiilor severe ale gingiei și țesuturilor parodontale cauzate de tulpini sensibile de organisme anaerobe, de exemplu, porphyromonas spp. și prevotella spp. catstreatment de infectii acute ale tractului respirator superior, cauzate de tulpini sensibile de pasteurella multocida, escherichia coli și staphylococcus intermedius grup (inclusiv s. pseudintermedius).

PEMETREXED DR. REDDY'S 500 mg România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

pemetrexed dr. reddy's 500 mg

dr. reddy's laboratories romania s.r.l. - pemetrexedum - pulb. pt. conc. pt.sol. perf. - 500mg - antimetaboliti analogi ai acidului folic

Tecentriq Uniunea Europeană - română - EMA (European Medicines Agency)

tecentriq

roche registration gmbh - atezolizumab - carcinoma, transitional cell; carcinoma, non-small-cell lung; urologic neoplasms; breast neoplasms; small cell lung carcinoma - agenți antineoplazici - urothelial carcinomatecentriq as monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic urothelial carcinoma (uc):- after prior platinum containing chemotherapy, or - who are considered cisplatin ineligible, and whose tumours have a pd-l1 expression ≥ 5% (see section 5. non-small cell lung cancer tecentriq, in combination with bevacizumab, paclitaxel and carboplatin, is indicated for the first-line treatment of adult patients with metastatic non-squamous non small cell lung cancer (nsclc). in patients with egfr mutant or alk-positive nsclc, tecentriq, in combination with bevacizumab, paclitaxel and carboplatin, is indicated only after failure of appropriate targeted therapies (see section 5. tecentriq, in combination with nab paclitaxel and carboplatin, is indicated for the first line treatment of adult patients with metastatic non-squamous nsclc who do not have egfr mutant or alk positive nsclc (see section 5. tecentriq as monotherapy is indicated for the first-line treatment of adult patients with metastatic non-small cell lung cancer (nsclc) whose tumours have a pd-l1 expression ≥ 50% tumour cells (tc) or ≥ 10% tumour-infiltrating immune cells (ic) and who do not have egfr mutant or alk-positive nsclc (see section 5. tecentriq cum este indicat în monoterapie pentru tratamentul pacienților adulți cu nsclc local avansat sau metastatic după chimioterapie anterioară. patients with egfr mutant or alk positive nsclc should also have received targeted therapies before receiving tecentriq (see section 5. small cell lung cancertecentriq, in combination with carboplatin and etoposide, is indicated for the first-line treatment of adult patients with extensive-stage small cell lung cancer (es-sclc) (see section 5. hepatocellular carcinomatecentriq, in combination with bevacizumab, is indicated for the treatment of adult patients with advanced or unresectable hepatocellular carcinoma (hcc) who have not received prior systemic therapy (see section 5. urothelial carcinomatecentriq as monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic urothelial carcinoma (uc):- after prior platinum containing chemotherapy, or- who are considered cisplatin ineligible, and whose tumours have a pd-l1 expression ≥ 5% (see section 5. non-small cell lung cancertecentriq as monotherapy is indicated for the first-line treatment of adult patients with metastatic non-small cell lung cancer (nsclc) whose tumours have a pd-l1 expression ≥ 50% tumour cells (tc) or ≥ 10% tumour-infiltrating immune cells (ic) and who do not have egfr mutant or alk-positive nsclc (see section 5. tecentriq cum este indicat în monoterapie pentru tratamentul pacienților adulți cu nsclc local avansat sau metastatic după chimioterapie anterioară. patients with egfr mutant or alk positive nsclc should also have received targeted therapies before receiving tecentriq (see section 5. triple-negative breast cancertecentriq in combination with nab-paclitaxel is indicated for the treatment of adult patients with unresectable locally advanced or metastatic triple-negative breast cancer (tnbc) whose tumours have pd-l1 expression ≥ 1% and who have not received prior chemotherapy for metastatic disease.

PROTEZA DE GAMBA, TIP CONVENTIONALA, DIN PIELE, COD I-GC-3-P România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

proteza de gamba, tip conventionala, din piele, cod i-gc-3-p

sc protmed protetika srl -

Mediu GC (Haemophyllus GC Medium Base) România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

mediu gc (haemophyllus gc medium base)

sc sanimed international impex srl -

Supliment Vitalex pentru haemophyllus (Vitalex GC Medium Supplement) România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

supliment vitalex pentru haemophyllus (vitalex gc medium supplement)

sc sanimed international impex srl -

PROTEZA DE GAMBA, TIP CONVENTIONALA, DIN MATERIAL PLASTIC, CU CONTACT TOTAL, COD I-GC-3 România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

proteza de gamba, tip conventionala, din material plastic, cu contact total, cod i-gc-3

sc protmed protetika srl -